Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Successful treatment of a patient with Epstein-Barr virus-positive B-cell lymphoproliferative disorder resembling post-transplant lymphoproliferative disorder using single-agent rituximab.

× No keyword cloud information.

12 in total

1. VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA.

Authors: M A EPSTEIN; B G ACHONG; Y M BARR
Journal: Lancet Date: 1964-03-28 Impact factor: 79.321

2. Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study.

Authors: Sylvain Choquet; Veronique Leblond; Raoul Herbrecht; Gérard Socié; Anne-Marie Stoppa; Peter Vandenberghe; Alain Fischer; Franck Morschhauser; Gilles Salles; Walter Feremans; Etienne Vilmer; Marie-Noelle Peraldi; Philippe Lang; Yvon Lebranchu; Eric Oksenhendler; Jeanne Luce Garnier; Thierry Lamy; Arnaud Jaccard; Augustin Ferrant; Fritz Offner; Olivier Hermine; Anne Moreau; Samira Fafi-Kremer; Patrice Morand; Lucienne Chatenoud; Nathalie Berriot-Varoqueaux; Loïc Bergougnoux; Noel Milpied
Journal: Blood Date: 2005-10-27 Impact factor: 22.113

3. Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with clonal lymphoproliferative disorders after orthotopic liver transplantation: a report of three cases.

Authors: S Zompi; M Tulliez; F Conti; V Leblond; P Gaulard; P Blanche; F Durand; D Ghandi; F Dreyfus; A Louvel; Y Calmus; D Bouscary
Journal: J Hepatol Date: 2000-03 Impact factor: 25.083

4. Transformation of foetal human keukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus.

Authors: J H Pope; M K Horne; W Scott
Journal: Int J Cancer Date: 1968-11-15 Impact factor: 7.396

5. [Efficacy of rituximab in lymphomatoid granulomatosis].

Authors: C Moudir-Thomas; A Foulet-Roge; M Plat; R Kaswin; P Lepic; P Solal-Celigny; F X Lebas
Journal: Rev Mal Respir Date: 2004-12 Impact factor: 0.622

Review 6. Epstein-barr virus-positive diffuse large B-cell lymphoma of the elderly: what we know so far.

Authors: Jorge J Castillo; Brady E Beltran; Roberto N Miranda; Semra Paydas; Eric S Winer; James N Butera
Journal: Oncologist Date: 2011-01-06

Review 7. Diagnosis and management of posttransplant lymphoproliferative disorder in solid-organ transplant recipients.

Authors: J K Preiksaitis; S Keay
Journal: Clin Infect Dis Date: 2001-07-01 Impact factor: 9.079

Review 8. Epstein-Barr virus: the impact of scientific advances on clinical practice.

Authors: Hilary Williams; Dorothy H Crawford
Journal: Blood Date: 2005-10-18 Impact factor: 22.113

9. Successful treatment of systemic and central nervous system lymphomatoid granulomatosis with rituximab.

Authors: A Zaidi; B Kampalath; W L Peltier; D H Vesole
Journal: Leuk Lymphoma Date: 2004-04

10. Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients.

Authors: Takashi Oyama; Koichi Ichimura; Ritsuro Suzuki; Junji Suzumiya; Koichi Ohshima; Yasushi Yatabe; Takio Yokoi; Masaru Kojima; Yoshikazu Kamiya; Hirofumi Taji; Yoshitoyo Kagami; Michinori Ogura; Hidehiko Saito; Yasuo Morishima; Shigeo Nakamura
Journal: Am J Surg Pathol Date: 2003-01 Impact factor: 6.394

1 in total

1. Targeting Epstein-Barr virus-transformed B lymphoblastoid cells using antibodies with T-cell receptor-like specificities.

Authors: Junyun Lai; Wei Jian Tan; Chien Tei Too; Joanna Ai Ling Choo; Lan Hiong Wong; Fatimah Bte Mustafa; Nalini Srinivasan; Angeline Pei Chiew Lim; Youjia Zhong; Nicholas R J Gascoigne; Brendon J Hanson; Soh Ha Chan; Jianzhu Chen; Paul A MacAry
Journal: Blood Date: 2016-06-23 Impact factor: 22.113

1 in total